Developer docs
API playgroundTry for free, no card

Search company profiles

Onyx Scientific Ltd.

Full company profile

uuid000coc3

Namestring
Onyx Scientific Ltd.
Legal namestring
Onyx Scientific Limited
Websiteurl
onyxipca.com
Company typeenum
Private
Founded yearint
2000
Descriptiontext

Onyx Scientific Ltd. is a UK-based small molecule contract development and manufacturing organization (CDMO) founded in 2000 in Sunderland. It provides integrated chemistry, manufacturing, and controls (CMC) services to pharmaceutical and biotechnology companies spanning preclinical process research and development, non-GMP and GMP manufacturing, analytical services, solid-state chemistry, and commercial API supply. The company holds an MHRA commercial API manufacturing license, FDA compliance, and operates six ISO 8 classified GMP laboratories, enabling delivery of Phase I–III clinical materials and low-volume commercial drug substance — particularly for orphan drug and niche product applications. Customers range from virtual pharma companies and startup biotechs (Ferronova, NRG Therapeutics, Pluvia Biotech, Domain Therapeutics, Pharvaris, Mironid, Epics Therapeutics, Small Pharma, Nuformix) to larger organizations such as Cancer Research UK and consulting firms (Cerebro CMC, Skead Consulting), with multi-year engagements documented including a 14+ year client relationship.

The company's technical platform is built around process chemistry and solid-state chemistry expertise. Physical operations span two Sunderland sites — the Silverbriar headquarters (R&D, non-GMP custom synthesis, dedicated solid-state laboratories, analytical method development) and the Wayfarer manufacturing facility (four non-GMP kilo-laboratories each with four 50L vessels, and six MHRA-accredited ISO 8 GMP suites) — plus Pisgah Labs Inc. in North Carolina, USA (acquired 2017). Specialized material science equipment added in 2026 includes the Technobis Crystalline PV/RR Line (real-time particle imaging at 0.63 micron resolution), Crystal16 parallel screening, Buchi S300 mini spray dryer with ultrasonic nozzle for amorphous solid dispersions, Buchi Lyovapor L-250 Pro lyophilization system, and MC DecJet 30 jet mill for scalable micronization. The technical team is described as chemist-led with a leading UK solid-state group built over 10 years, specializing in challenging molecules including DCS Class II and IV compounds.

Onyx Scientific is a wholly-owned subsidiary of Ipca Laboratories Ltd., an Indian pharmaceutical company that acquired the firm in 2011, and operates as Ipca's CDMO division. Revenue is generated through project-based contract services (professional services model), with bespoke quotes tied to molecule complexity, scale, and phase requirements rather than publicly disclosed pricing. The go-to-market is direct B2B enterprise sales — consultative engagement at RFP stage with proposals tailored to specific project requirements — supported by business development managers covering UK/Europe and North America territories. Distribution is exclusively direct with no reseller or distributor channels, and marketing is conducted via LinkedIn, a content-driven knowledge hub, whitepapers, industry events, and virtual site tours.

Short descriptiontext

Onyx Scientific is a UK-based small molecule CDMO that provides integrated chemistry, manufacturing, and controls (CMC) services — from preclinical process development through GMP and commercial API manufacturing — to pharmaceutical and biotechnology companies.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersSunderland, United Kingdom
HQ citystring
Sunderland
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
small molecule CDMO, API development, GMP manufacturing, process chemistry, solid state chemistry
Industry4 codes
PRIMARYHLAGABAA
Small-Molecule API & Intermediates CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGABAK
Clinical Trial Material (CTM) Manufacturing & Supply CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGABAB
Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGAKAL
Quality Engineering & Risk Management (ICH Q9/Q10, validation, change control)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
NAICS code3 codes
  • Pharmaceutical and Medicine Manufacturing32541
  • Pharmaceutical Preparation Manufacturing325412
  • Pharmaceutical and Medicine Manufacturing3254
SIC code3 codes
  • Pharmaceutical Preparations2834
  • Medicinal Chemicals & Botanical Products2833
  • Services-Commercial Physical & Biological Research8731
Product category
Pharmaceutical Contract Manufacturing (CDMO)
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Contract Development and Manufacturing Services
TypeProfessional Services
Description

Project-based contract services for API development and manufacturing across preclinical, clinical (Phase I-III), and commercial phases. Revenue generated through bespoke project fees, scale-up campaigns, and manufacturing batches. Services include process research & development, GMP manufacturing, analytical services, and solid-state chemistry.

onyxipca.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Onyx Scientific Ltd. is a contract development and manufacturing organization (CDMO) for small molecule active pharmaceutical ingredients (APIs), providing integrated CMC services spanning process research and development, non-GMP scale-up, GMP manufacturing for Phase I-III clinical materials, analytical services, and solid-state chemistry. The company operates from MHRA-accredited facilities in Sunderland, UK (Silverbriar and Wayfarer sites) and Pisgah Forest, North Carolina, delivering bespoke projects from preclinical through commercial supply. It operates as the CDMO division of Ipca Laboratories Ltd.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Scale-up capacity increased by 50% through facility expansion
+3 more records
Product overview1 text field

Onyx Scientific is a small molecule CDMO (Contract Development and Manufacturing Organization) offering integrated CMC services from preclinical through commercial manufacturing. Their service portfolio includes Process Research & Development, GMP Manufacturing, Analytical Services, Solid State Chemistry (salt/co-crystal screening, polymorphism, crystallization development), and Commercial API manufacturing. The company operates facilities in Sunderland, UK (Silverbriar and Wayfarer sites) and North Carolina, US (via Pisgah Labs Inc.), and is the CDMO division of Ipca Laboratories. Services are delivered through a chemist-led, phase-appropriate approach with integrated departments working collaboratively from lead nomination through commercial supply.

Product and service1 record
1Process Research & Development (PR&D)
Scale indicator12 records

Each record includes

Type, Value, Description, Source

Recent move10 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

India-based API manufacturer and CDMO offering similar small molecule API services with cost advantages from Indian operations, comparable to Ipca's parent positioning.

TypeBroad incumbent
Description

Global CDMO leader with substantial small molecule API development and manufacturing capabilities, serving as the scale benchmark that defines Onyx's niche positioning.

TypeDirect peer
Description

European-headquartered CDMO offering small molecule API development and manufacturing with comparable MHRA/FDA-credentialed GMP infrastructure and pharmaceutical customer base.

TypeEmerging player
Description

India-based CDMO offering small molecule API development and GMP manufacturing with comparable services, emerging as a cost-competitive alternative for global biotech clients.

TypeBroad incumbent
Description

Sanofi-spinoff API manufacturer and CDMO serving European and global pharma with broader product portfolio and larger commercial API scale than Onyx.

TypeDirect peer
Description

Portugal-based small molecule CDMO specializing in API development, solid-state chemistry, and particle engineering with similar integrated service model and pharmaceutical customer base.

TypeDirect peer
Description

US-based CDMO offering small molecule API development, GMP manufacturing, and analytical services with comparable scale and similar pharmaceutical/biotech customer profile.

TypeDirect peer
Description

Small molecule API CDMO with similar service portfolio spanning drug substance development through commercial manufacturing, currently operating under Symeres ownership.

TypeDirect peer
Description

European small molecule API CDMO with cGMP manufacturing, solid form services, and similar integrated CMC offerings targeting pharma and biotech customers.

TypeDirect peer
Description

UK-headquartered small molecule API CDMO offering similar integrated CMC services from preclinical through commercial, with comparable employee scale and MHRA/FDA regulatory credentials.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers13 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature10 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Onyx Scientific Ltd.

Pharmaceutical Contract Manufacturing (CDMO)onyxipca.com

Onyx Scientific is a UK-based small molecule CDMO that provides integrated chemistry, manufacturing, and controls (CMC) services — from preclinical process development through GMP and commercial API manufacturing — to pharmaceutical and biotechnology companies.

What Onyx Scientific Ltd. does

Onyx Scientific Ltd. is a UK-based small molecule contract development and manufacturing organization (CDMO) founded in 2000 in Sunderland. It provides integrated chemistry, manufacturing, and controls (CMC) services to pharmaceutical and biotechnology companies spanning preclinical process research and development, non-GMP and GMP manufacturing, analytical services, solid-state chemistry, and commercial API supply. The company holds an MHRA commercial API manufacturing license, FDA compliance, and operates six ISO 8 classified GMP laboratories, enabling delivery of Phase I–III clinical materials and low-volume commercial drug substance — particularly for orphan drug and niche product applications. Customers range from virtual pharma companies and startup biotechs (Ferronova, NRG Therapeutics, Pluvia Biotech, Domain Therapeutics, Pharvaris, Mironid, Epics Therapeutics, Small Pharma, Nuformix) to larger organizations such as Cancer Research UK and consulting firms (Cerebro CMC, Skead Consulting), with multi-year engagements documented including a 14+ year client relationship.

The company's technical platform is built around process chemistry and solid-state chemistry expertise. Physical operations span two Sunderland sites — the Silverbriar headquarters (R&D, non-GMP custom synthesis, dedicated solid-state laboratories, analytical method development) and the Wayfarer manufacturing facility (four non-GMP kilo-laboratories each with four 50L vessels, and six MHRA-accredited ISO 8 GMP suites) — plus Pisgah Labs Inc. in North Carolina, USA (acquired 2017). Specialized material science equipment added in 2026 includes the Technobis Crystalline PV/RR Line (real-time particle imaging at 0.63 micron resolution), Crystal16 parallel screening, Buchi S300 mini spray dryer with ultrasonic nozzle for amorphous solid dispersions, Buchi Lyovapor L-250 Pro lyophilization system, and MC DecJet 30 jet mill for scalable micronization. The technical team is described as chemist-led with a leading UK solid-state group built over 10 years, specializing in challenging molecules including DCS Class II and IV compounds.

Onyx Scientific is a wholly-owned subsidiary of Ipca Laboratories Ltd., an Indian pharmaceutical company that acquired the firm in 2011, and operates as Ipca's CDMO division. Revenue is generated through project-based contract services (professional services model), with bespoke quotes tied to molecule complexity, scale, and phase requirements rather than publicly disclosed pricing. The go-to-market is direct B2B enterprise sales — consultative engagement at RFP stage with proposals tailored to specific project requirements — supported by business development managers covering UK/Europe and North America territories. Distribution is exclusively direct with no reseller or distributor channels, and marketing is conducted via LinkedIn, a content-driven knowledge hub, whitepapers, industry events, and virtual site tours.

Onyx Scientific Ltd. firmographics

Firmographics
Name
Onyx Scientific Ltd.
Legal name
Onyx Scientific Limited
Website
https://onyxipca.com
Company type
Private
Founded year
2000
Operating status
Operating
Headcount range
51–100 employees
Short description
Onyx Scientific is a UK-based small molecule CDMO that provides integrated chemistry, manufacturing, and controls (CMC) services — from preclinical process development through GMP and commercial API manufacturing — to pharmaceutical and biotechnology companies.
Ownership category
akta.pro rank

Onyx Scientific Ltd. industry classification

Industry
Product category
Pharmaceutical Contract Manufacturing (CDMO)
NAICS
Pharmaceutical and Medicine Manufacturing (32541), Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)
SIC
Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGABAA
Small-Molecule API & Intermediates CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGABAK
Clinical Trial Material (CTM) Manufacturing & Supply CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGABAB
Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGAKAL
Quality Engineering & Risk Management (ICH Q9/Q10, validation, change control)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)

Keywords

  • Small molecule CDMO
  • API development
  • GMP manufacturing
  • Process chemistry
  • Solid state chemistry

Where Onyx Scientific Ltd. is headquartered

Location

Headquarters

HQ city
Sunderland
HQ country
United Kingdom
HQ region
Europe

Offices3 records

Markets served

Onyx Scientific Ltd. business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain

Revenue model

  1. Contract Development and Manufacturing Services: Project-based contract services for API development and manufacturing across preclinical, clinical (Phase I-III), and commercial phases. Revenue generated through bespoke project fees, scale-up campaigns, and manufacturing batches. Services include process research & development, GMP manufacturing, analytical services, and solid-state chemistry.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Onyx Scientific Ltd. product offering

Product offering

Core offering

Onyx Scientific Ltd. is a contract development and manufacturing organization (CDMO) for small molecule active pharmaceutical ingredients (APIs), providing integrated CMC services spanning process research and development, non-GMP scale-up, GMP manufacturing for Phase I-III clinical materials, analytical services, and solid-state chemistry. The company operates from MHRA-accredited facilities in Sunderland, UK (Silverbriar and Wayfarer sites) and Pisgah Forest, North Carolina, delivering bespoke projects from preclinical through commercial supply. It operates as the CDMO division of Ipca Laboratories Ltd.

Product overview

Onyx Scientific is a small molecule CDMO (Contract Development and Manufacturing Organization) offering integrated CMC services from preclinical through commercial manufacturing. Their service portfolio includes Process Research & Development, GMP Manufacturing, Analytical Services, Solid State Chemistry (salt/co-crystal screening, polymorphism, crystallization development), and Commercial API manufacturing. The company operates facilities in Sunderland, UK (Silverbriar and Wayfarer sites) and North Carolina, US (via Pisgah Labs Inc.), and is the CDMO division of Ipca Laboratories. Services are delivered through a chemist-led, phase-appropriate approach with integrated departments working collaboratively from lead nomination through commercial supply.

Differentiator

Problem solved

Functional benefit

Products and services

  • Process Research & Development (PR&D)

Quantifiable outcome

  • Scale-up capacity increased by 50% through facility expansion
  • +3 more outcomes

Companies that use Onyx Scientific Ltd.

Customer profile

Named customers13 records

Segments4 records

Ideal customer profiles4 records

Onyx Scientific Ltd. technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature10 records

Onyx Scientific Ltd. partnerships and signals

Strategic signal

Scale indicators12 records

Recent moves10 records

Expansion highlights6 records

Onyx Scientific Ltd. competitors and assessment

Company assessment

Emerging players

  • Neuland Laboratories: India-based API manufacturer and CDMO offering similar small molecule API services with cost advantages from Indian operations, comparable to Ipca's parent positioning.
  • Sai Life Sciences: India-based CDMO offering small molecule API development and GMP manufacturing with comparable services, emerging as a cost-competitive alternative for global biotech clients.

Broad incumbents

  • Lonza Small Molecules: Global CDMO leader with substantial small molecule API development and manufacturing capabilities, serving as the scale benchmark that defines Onyx's niche positioning.
  • EUROAPI: Sanofi-spinoff API manufacturer and CDMO serving European and global pharma with broader product portfolio and larger commercial API scale than Onyx.

Direct peers

  • Corden Pharma: European-headquartered CDMO offering small molecule API development and manufacturing with comparable MHRA/FDA-credentialed GMP infrastructure and pharmaceutical customer base.
  • Hovione: Portugal-based small molecule CDMO specializing in API development, solid-state chemistry, and particle engineering with similar integrated service model and pharmaceutical customer base.
  • Alcami Corporation: US-based CDMO offering small molecule API development, GMP manufacturing, and analytical services with comparable scale and similar pharmaceutical/biotech customer profile.
  • Cambrex: Small molecule API CDMO with similar service portfolio spanning drug substance development through commercial manufacturing, currently operating under Symeres ownership.
  • AGC Pharma Chemicals: European small molecule API CDMO with cGMP manufacturing, solid form services, and similar integrated CMC offerings targeting pharma and biotech customers.
  • Sterling Pharma Solutions: UK-headquartered small molecule API CDMO offering similar integrated CMC services from preclinical through commercial, with comparable employee scale and MHRA/FDA regulatory credentials.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Onyx Scientific Ltd. social profiles

Digital presence

Onyx Scientific Ltd. compliance and trust

Trust signal

Compliance3 records

Onyx Scientific Ltd. financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Onyx Scientific Ltd. leadership team

Management profile

Number of profiles

Profiles9 records

Onyx Scientific Ltd. subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Onyx Scientific Ltd. funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Onyx Scientific Ltd. M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Onyx Scientific Ltd.

What does Onyx Scientific Ltd. do?

Onyx Scientific Ltd. is a contract development and manufacturing organization (CDMO) for small molecule active pharmaceutical ingredients (APIs), providing integrated CMC services spanning process research and development, non-GMP scale-up, GMP manufacturing for Phase I-III clinical materials, analytical services, and solid-state chemistry. The company operates from MHRA-accredited facilities in Sunderland, UK (Silverbriar and Wayfarer sites) and Pisgah Forest, North Carolina, delivering bespoke projects from preclinical through commercial supply. It operates as the CDMO division of Ipca Laboratories Ltd.

Is Onyx Scientific Ltd. a public or private company?

Onyx Scientific Ltd. is a private company. It is classified as corporate owned and is currently operating.

When was Onyx Scientific Ltd. founded?

Onyx Scientific Ltd. was founded in 2000. It employs 51 to 100 people.

Where is Onyx Scientific Ltd. based?

Onyx Scientific Ltd. is headquartered in Sunderland, United Kingdom, in the Europe region.

How does Onyx Scientific Ltd. make money?

One revenue line is on record: contract Development and Manufacturing Services.

Who are Onyx Scientific Ltd.'s main competitors?

Emerging players on record are Neuland Laboratories and Sai Life Sciences. Broad incumbents are Lonza Small Molecules and EUROAPI. Direct peers are Corden Pharma, Hovione, Alcami Corporation, Cambrex, AGC Pharma Chemicals and Sterling Pharma Solutions.

Does Onyx Scientific Ltd. have an API?

No public API is recorded for Onyx Scientific Ltd..

What industry is Onyx Scientific Ltd. in?

Onyx Scientific Ltd.'s product category is Pharmaceutical Contract Manufacturing (CDMO). Its primary akta.pro industry code is HLAGABAA, Small-Molecule API & Intermediates CDMO, with a secondary code of HLAGABAK, Clinical Trial Material (CTM) Manufacturing & Supply CDMO. Its NAICS code is 32541 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals